January 23, 2026 Posted by: Categories: No Comments The European Medicines Agency (EMA) published updated information on several medicines: Skyrizi | European Medicines Agency (EMA) Tagrisso | European Medicines Agency (EMA) Darzalex | European Medicines Agency (EMA) Wegovy | European Medicines Agency (EMA) Rybelsus | European Medicines Agency (EMA) Xenpozyme | European Medicines Agency (EMA) Daptomycin Hospira | European Medicines Agency (EMA) Evrysdi | European Medicines Agency (EMA) Nyvepria | European Medicines Agency (EMA) Finlee | European Medicines Agency (EMA) Erivedge | European Medicines Agency (EMA) Nuvaxovid | European Medicines Agency (EMA) Bavencio | European Medicines Agency (EMA) Opatanol | European Medicines Agency (EMA)
